Zervimesine

Overview

Zervimesine (CT1812) is an orally active and brain penetrant sigma-2 receptor antagonist with a K i of 8.5 nM. Zervimesine can be used for the research of Alzheimer’s disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Sigma Receptor

Product Information

• Catalog No.: HY-111669
• CAS No.: 1802632-22-9
• Molecular Formula: C24H33NO4S
• Molecular Weight: 431.59
• Purity: 99.01%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.08 mg/mL (4.82 mM); Clear solution
• Availability: In-stock

Source

Original product source